Dr. Batlevi on Emerging Therapies in Follicular Lymphoma


Connie L. Batlevi, MD, PhD, discusses emerging therapies in follicular lymphoma.

Connie L. Batlevi, MD, PhD, a medical oncologist specializing in lymphoma at Memorial Sloan Kettering Cancer Center, discusses emerging therapies in follicular lymphoma.

​Several emerging therapies ​in the follicular lymphoma pipeline ​have shown encouraging data, says Batlevi.

Strategies based on modulating immune response have comprised a significant area of research, ​Batlevi explains. Additionally, the utility of CAR T-cell therapy, antibody​-drug conjugates, and bispecific antibodies ​is also being evaluated.

​Future research efforts should focus on identifying an optimal sequencing method ​for patients with follicular lymphoma, especially as more options are introduced to the armamentarium, Batlevi concludes. 

Related Videos
Akriti Jain, MD
Samer A. Srour, MB ChB, MS
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Julia Foldi, MD, PhD
Carmen Guerra, MD, MSCE, FACP
Kara N. Maxwell, MD, PhD
Abdulrahman Sinno, MD
Margaret E. Gatti-Mays, MD, MPH, FACP, of The Ohio State University Comprehensive Cancer Center
Erin K. Crane, MD, MPH
Omid Hamid, MD